 | • レポートコード：360iR22NB103 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、221ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に9,549.49百万ドルであった世界の高度創傷治療市場規模が、2022年に10,494.44百万ドルになり、2027年まで年平均10.07%で成長して16,984.40百万ドルに達すると予測しています。本レポートでは、高度創傷治療の世界市場を広く調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（創傷治療、滲出液管理、感染管理、治療装置）分析、用途別（急性創傷、やけど・外傷、慢性創傷、手術創・瘢痕管理）分析、エンドユーザー別（保健所、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめています。本書では、3m Company、Acell、Advancis Medical LLC、B. Braun Melsungen AG、Cardinal Health、Coloplast A/S、Convatec Group PLC、Dermarite Industries LLC、Deroyal Industries Inc.、Hollister Inc.、Integra Lifesciences Holdings Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の高度創傷治療市場規模：製品別 - 創傷治療用製品の市場規模 - 滲出液管理用製品の市場規模 - 感染管理用製品の市場規模 - 治療用装置の市場規模 ・世界の高度創傷治療市場規模：用途別 - 急性創傷における市場規模 - やけど・外傷における市場規模 - 慢性創傷における市場規模 - 手術創・瘢痕管理における市場規模 ・世界の高度創傷治療市場規模：エンドユーザー別 - 保健所における市場規模 - 病院における市場規模 ・世界の高度創傷治療市場規模：地域別 - 南北アメリカの高度創傷治療市場規模 アメリカの高度創傷治療市場規模 カナダの高度創傷治療市場規模 ブラジルの高度創傷治療市場規模 … - アジア太平洋の高度創傷治療市場規模 日本の高度創傷治療市場規模 中国の高度創傷治療市場規模 インドの高度創傷治療市場規模 韓国の高度創傷治療市場規模 台湾の高度創傷治療市場規模 … - ヨーロッパ/中東/アフリカの高度創傷治療市場規模 イギリスの高度創傷治療市場規模 ドイツの高度創傷治療市場規模 フランスの高度創傷治療市場規模 ロシアの高度創傷治療市場規模 … - その他地域の高度創傷治療市場規模 ・競争状況 ・企業情報 |
The Global Advanced Wound Care Market size was estimated at USD 9,549.49 million in 2021 and expected to reach USD 10,494.44 million in 2022, and is projected to grow at a CAGR 10.07% to reach USD 16,984.40 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Advanced Wound Care to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Active Wound Care, Exudate Management, Infection Management, and Therapy Devices. The Active Wound Care is further studied across Growth Factors and Skin Substitutes. The Exudate Management is further studied across Alginate Dressings, Foam Dressings, Hydrocolloids Dressings, and Hydrogel Dressings. The Infection Management is further studied across Collagen Dressings, Non-Silver Dressings, and Silver Wound Dressings. The Therapy Devices is further studied across Electromagnetic Therapy Devices, Negative Pressure Wound Therapy Devices, and Oxygen and Hyperbaric Oxygen Devices.
Based on Application, the market was studied across Acute Wounds, Burns & Trauma, Chronic Wounds, and Surgical Wounds & Scar Management. The Burns & Trauma is further studied across First-Degree, Second-Degree, and Third-Degree,. The Chronic Wounds is further studied across Arterial Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, and Venous Leg Ulcers.
Based on End User, the market was studied across Community Health Service Centers and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Advanced Wound Care market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Advanced Wound Care Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Advanced Wound Care Market, including 3m Company, Acell, Advancis Medical LLC, B. Braun Melsungen AG, Cardinal Health, Coloplast A/S, Convatec Group PLC, Dermarite Industries LLC, Deroyal Industries Inc., Hollister Inc., Integra Lifesciences Holdings Corporation, Kerecis, Lohmann & Rauscher International Gmbh & Co. KG, Medline Industries, Inc., Mil Laboratories Pvt. Ltd., Mimedx Group, Misonix, Mölnlycke Health Care AB, Organogenesis Holdings Inc., Paul Hartmann AG, Shield Line, Smith & Nephew PLC, Welcare Industries SPA, Winner Medical Co. Ltd., and Zimmer Biomet Holdings Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Advanced Wound Care Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Advanced Wound Care Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Advanced Wound Care Market?
4. What is the competitive strategic window for opportunities in the Global Advanced Wound Care Market?
5. What are the technology trends and regulatory frameworks in the Global Advanced Wound Care Market?
6. What is the market share of the leading vendors in the Global Advanced Wound Care Market?
7. What modes and strategic moves are considered suitable for entering the Global Advanced Wound Care Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of obesity due to unhealthy lifestyle
5.1.1.2. Rising geriatric population and need for medical attention
5.1.1.3. Growing prevalence of diabetes patients
5.1.2. Restraints
5.1.2.1. Risks linked with the use of advanced wound care products
5.1.2.2. High cost of advanced devices
5.1.3. Opportunities
5.1.3.1. Technological advancement and innovation in product
5.1.3.2. Amalgamation strategy by companies to improve their market presence
5.1.4. Challenges
5.1.4.1. Stringent regulatory policies and product approvals
5.2. Cumulative Impact of COVID-19
6. Advanced Wound Care Market, by Product
6.1. Introduction
6.2. Active Wound Care
6.3.1. Growth Factors
6.3.2. Skin Substitutes
6.3. Exudate Management
6.4.1. Alginate Dressings
6.4.2. Foam Dressings
6.4.3. Hydrocolloids Dressings
6.4.4. Hydrogel Dressings
6.4. Infection Management
6.5.1. Collagen Dressings
6.5.2. Non-Silver Dressings
6.5.3. Silver Wound Dressings
6.5. Therapy Devices
6.6.1. Electromagnetic Therapy Devices
6.6.2. Negative Pressure Wound Therapy Devices
6.6.3. Oxygen and Hyperbaric Oxygen Devices
7. Advanced Wound Care Market, by Application
7.1. Introduction
7.2. Acute Wounds
7.3. Burns & Trauma
7.4.1. First-Degree
7.4.2. Second-Degree
7.4.3. Third-Degree,
7.4. Chronic Wounds
7.5.1. Arterial Ulcers
7.5.2. Diabetic Foot Ulcers
7.5.3. Pressure Ulcers
7.5.4. Venous Leg Ulcers
7.5. Surgical Wounds & Scar Management
8. Advanced Wound Care Market, by End User
8.1. Introduction
8.2. Community Health Service Centers
8.3. Hospitals
9. Americas Advanced Wound Care Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Advanced Wound Care Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Advanced Wound Care Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3m Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Acell
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Advancis Medical LLC
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. B. Braun Melsungen AG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Cardinal Health
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Coloplast A/S
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Convatec Group PLC
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Dermarite Industries LLC
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Deroyal Industries Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Hollister Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Integra Lifesciences Holdings Corporation
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Kerecis
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Lohmann & Rauscher International Gmbh & Co. KG
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Medline Industries, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Mil Laboratories Pvt. Ltd.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Mimedx Group
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Misonix
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Mölnlycke Health Care AB
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Organogenesis Holdings Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Paul Hartmann AG
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Shield Line
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Smith & Nephew PLC
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Welcare Industries SPA
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Winner Medical Co. Ltd.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Zimmer Biomet Holdings Inc.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing